Patient-specific
dosing recommendations

Gadopiclenol has the highest relaxivity of all GBCAs today combined with high stability.^†,1
It can make a difference to your patients because: 
• Gd exposure is reduced per procedure for all patients, including pediatrics 

• The cumulative lifetime dose is reduced, which may be of clinical value, especially in vulnerable patients undergoing repeated or closely-spaced MRIs ^2-4

• The rate of lesion detection is comparable to a standard GBCA at the dose of 0.1 mmol/kg.^1,5,6
 

† Together with Elucirem (Gadopiclenol)